
Adverse Events as End Points: The Need to Account for Both Sides of the Same Coin
Author(s) -
Aizpuru Felipe
Publication year - 2017
Publication title -
journal of the american heart association
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.494
H-Index - 85
ISSN - 2047-9980
DOI - 10.1161/jaha.117.006018
Subject(s) - medicine , adverse effect , intensive care medicine
The current issue of JAHA features a very welcome article[1][1] on the need for joint reporting of clinical end points and safety events in clinical trials, especially in large, multisite‐multicountry trials. The article refers to a particular trial on acute coronary syndrome,[2][2] the Apixaban